The elevated expression of SLC14A1, phospho-Smad2, and Snail not only corroborates their synergistic interaction but also underscores their potential as significant biomarkers and therapeutic targets for managing CRC progression and metastasis. Here, SMAD2 is linked to colorectal carcinoma.